Placebo response in sham-acupuncture-controlled trials for migraine: A systematic review and meta-analysis.

If you've ever wondered why people sometimes feel better after a "fake" treatment, you're not alone — and a new scientific review may help explain this phenomenon in the context of acupuncture for migraines.

Researchers analyzed 21 clinical trials involving 1,177 patients to understand what's called the "placebo response" in sham acupuncture — a practice used in research where needles are placed at non-therapeutic points or don't fully penetrate the skin, serving as a control comparison to real acupuncture.

What they found was striking: about 34% of patients who received sham acupuncture still reported meaningful improvement in their migraines. But the benefits didn't stop at headache frequency and pain intensity. Patients receiving sham acupuncture also showed measurable improvements in anxiety, depression, and overall quality of life — including both physical and emotional wellbeing.

One factor stood out as particularly important: how often patients received treatment. Trials where acupuncture was administered more frequently showed a much higher placebo response rate (49%) compared to those with less frequent sessions (14%). This suggests that the ritual of regular care itself — the appointments, the attention, the therapeutic relationship — may play a powerful role in how patients feel.

For migraine sufferers, this research offers an encouraging message: even the act of seeking acupuncture care appears to bring real, measurable relief. Of course, studies consistently show that true acupuncture outperforms sham treatment, meaning the specific technique matters too.

This review also highlights an important point for anyone considering acupuncture: the experience of care — including how frequently you're treated — may be just as important as the treatment itself in your overall outcomes.

To get the most from acupuncture treatment for migraines, seek out a licensed, qualified acupuncture practitioner who can design a treatment plan tailored to your specific needs.

This systematic review and meta-analysis of 21 RCTs (n = 1,177) quantified the placebo response in sham-acupuncture-controlled migraine trials. The pooled sham response rate was 0.34 (RD, 95% CI 0.23–0.45; I² = 89.8%), indicating substantial but heterogeneous placebo effects. Sham acupuncture produced statistically significant improvements in pain intensity (SMD −0.56), episode frequency (SMD −0.55), anxiety (SMD −0.49), depression (SMD −0.21), and multiple Migraine-Specific Quality-of-Life and SF domains. Notably, treatment frequency was the only variable significantly associated with placebo response magnitude — high-frequency protocols yielded an RD of 0.49 versus 0.14 for low-frequency protocols (p = 0.00). The high I² across outcomes underscores considerable between-trial variability. Clinically, these findings suggest that non-specific effects — including therapeutic ritual, patient expectation, and practitioner contact frequency — are significant contributors to acupuncture trial outcomes. Future trial designs should stratify or control for treatment frequency and more comprehensively account for contextual factors when interpreting verum-versus-sham differences.